Patrick D. Walsh
Patrick, who joined Ampersand as an Operating Partner in 2018, was the CEO of former Ampersand portfolio company, Avista Pharma Solutions. He currently is the CEO of Ampersand portfolio company TriPharm. He has extensive experience directing pharmaceutical manufacturing operations on a global scale in parenteral, API, specialty pharmaceutical, formulation, manufacturing and analytical contract development organizations, and has served as Chairman, Non-Executive Chairman and a company Director in twelve organizations. Prior to Avista, Patrick was CEO of AAIPharma Services, where he led the successful growth strategy culminating in the sale of the company for a 4.6 times return on invested capital. Prior executive roles include CEO roles in several life science companies and President & COO of Gensia-Sicor. Patrick holds a degree in General Studies from Lewis & Clark College.